SPIRIVA RESPIMAT 1.25 mcg/Puff
(2 Puffs, 1 time each day) for Asthma
SPIRIVA RESPIMAT is approved for patients with asthma1
SPIRIVA RESPIMAT has asthma-specific dosing: 1.25 mcg/puff (2 puffs, 1 time each day). In the treatment of asthma, the maximum benefits in lung function may take up to 4 to 8 weeks of dosing.1
In clinical trials, the improvement in lung function compared to placebo was maintained for 24 hours. Two puffs of the 1.25 mcg formulation was the lowest efficacious dose across clinical trials.1
Why wait to add SPIRIVA RESPIMAT
when you can improve your patient’s breathing
Using SPIRIVA RESPIMAT as add-on maintenance therapy for asthma
SPIRIVA RESPIMAT can be used as add-on maintenance therapy in asthma patients. In clinical trials, SPIRIVA RESPIMAT was evaluated against a background of ICS or ICS/LABA treatment.
SPIRIVA RESPIMAT is a maintenance bronchodilator used 1 time each day and should not be used for immediate relief of breathing problems. In the event of an attack, a rapid-acting beta2‑agonist should be used.1
ICS=inhaled corticosteroid; LABA=long-acting beta2-agonist.
See how to use SPIRIVA RESPIMAT
You and your patients can watch this video to learn more about the RESPIMAT mist.Watch Video
Eligible patients with asthma
may pay as little as $0*
*Eligible commercially insured patients or patient guardians who are 18 years or older may pay as little as $0/month with a maximum savings up to $100/monthly prescription. Card valid for 12 fills per year with benefits not to exceed program expiration on 12/31/2019. If you live in Massachusetts, card expires on the earlier of December 31, 2019, or date AB rated generic equivalent is available. Other state restrictions may apply. One card per patient, not transferable, and cannot be combined with any other offer. Card not accepted in Veteran’s Affairs pharmacies. Program not health insurance. You must present this card to the pharmacist with your Spiriva Respimat prescription to participate. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Offer not valid for patients without commercial coverage or patients whose prescriptions for Spiriva Respimat are eligible to be reimbursed, in whole or in part, by any governmental program such as Medicaid, Medicare or any state patient or pharmaceutical assistance program and where prohibited by law. Offer may change at any time, without notice.